Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

NCT07357532 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Carcinoma

Interventions

DRUG: Adebrelimab Injection
DRUG: Apatinib Mesylate Tablets

Sponsor

Peking University Cancer Hospital & Institute